Bronchogen Peptide Description

Bronchogen is a Khavinson bioregulator peptide composed of four amino acids (Ala-Glu-Asp-Leu) designed for respiratory research applications. This short peptide demonstrates molecular interactions with bronchial epithelium and lung tissue in laboratory studies.

Research in rat models shows the effect of Bronchogen on inflammatory pathways, epithelial cells, and surfactant production. Studies indicate potential applications in chronic obstructive pulmonary disease (COPD) research, examining cellular mechanisms affecting lung function and bronchial inflammation.

Intended for research use only in controlled laboratory environments studying respiratory biology.

Our Product Quality Guarantee

Every Limitless Biotech compound undergoes independent testing for endotoxins and sterility, meeting rigorous research standards through our systematic quality protocols and proactive manufacturing processes.

Buy Bronchogen From Limitless Biotech

Limitless Biotech provides USA-manufactured Bronchogen for sale with verified molecular sequences and purity through comprehensive third-party testing. We ensure research quality with same-day shipping and dedicated customer support for your scientific endeavors.

Container:: Glass Vial
Weight:: 20mg
Amino Acid Sequence:: Ala-Glu-Asp-Leu
Molecular Formula:: C18H30N4O9
Molecular Weight:: 446.45 g/mol
Synonyms:: AEDL, Ala-Glu-Asp-Leu
Purity:: ≥98% (HPLC)
Solubility:: Soluble in BAC water
Storage Conditions:: Store at -20°C, tightly sealed, away from heat and moisture
Physical Appearance:: White lyophilized powder
Quality Verification:: Third-party tested by certified laboratory
Manufacturing Standard:: Synthetic, pharmaceutical-grade
Intended Application:: In vitro research applications only

At Limitless Biotech, we provide comprehensive Certificates of Analysis (COAs) for all of our research-only peptides to ensure transparency, purity, and quality in every batch. Each COA includes detailed analytical data that allows researchers to verify identity, concentration, and integrity, supporting reliable and reproducible scientific work. Our commitment to rigorous testing helps researchers move forward with confidence in the materials they use.

Lyophilized Bronchogen #1247 Sterility COA

Lyophilized Bronchogen #1247 Purity COA

Lyophilized Bronchogen #1247 Endotoxin COA

Research

Bronchogen (AEDL) represents a tetrapeptide bioregulator developed through the Khavinson peptide research program, with studies focusing on respiratory tissue function and bronchial epithelial mechanisms.

Epithelial Regeneration Studies

Research demonstrates Bronchogen’s effects on bronchial epithelial cell behavior in laboratory models of obstructive lung pathology. The peptide influences epithelial cell proliferation and differentiation processes that maintain airway surface integrity[1]. Studies indicate the AEDL sequence supports regenerative capacity of bronchial epithelial cells, which serve barrier function roles. Laboratory findings suggest the peptide influences cellular kinetics involved in lung tissue repair. Research shows Bronchogen affects signaling pathways that regulate cell growth, migration, and differentiation. These mechanisms support structural integrity of respiratory epithelium in experimental models.

Anti-inflammatory Properties

Laboratory studies examine Bronchogen’s ability to modulate inflammatory responses in respiratory tissue models. Research indicates the peptide helps regulate production of inflammatory mediators through cellular signaling pathway modulation[2]. The AEDL sequence demonstrates tissue protective effects involving antioxidant mechanisms that protect cells from oxidative stress damage. Studies suggest these protective mechanisms support natural resolution of inflammatory processes in respiratory tissues.